Hosted on MSN
Why is this ASX 200 share charging 7% higher today?
Clarity Pharmaceuticals Ltd (ASX: CU6) shares are having a strong session on Tuesday. At the time of writing, the ASX 200 share is up 7% to $3.52 after the company released a clinical trial update.
The cast of Emmerdale have spoken out following tonight's huge episode in which Cain Dingle revealed the truth to his wife Moira about his cancer diagnosis. Viewers know that Cain was recently ...
Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...
FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
Bayer is directing investor attention back to its pharmaceutical development pipeline with a strategic move that signals more than just business as usual. The f ...
Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...
"Cancer took my dad when he was 56. I was 24 then. I came to believe I would be denied a long life, too. I didn’t admit that to people," columnist Terry Woster writes.
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY (piflufolastat F 18) with the potential for larger batches and greater pati ...
The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release. As Healio previously reported, ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agent combines thediagnostic performance of PYLARIFY® (piflufolastat F 18) with the potential for la ...
An investigational approach to diagnosis of prostate cancer uses sound waves to extract "bubbles of information" from cells. ...
Cancers of the reproductive and urinary organs, known as genitourinary cancers, affect millions of people worldwide each year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results